Cocrystal Pharma, Inc. (COCP)
1.21
+0.07
(+6.14%)
USD |
NASDAQ |
Sep 18, 16:00
1.23
+0.02
(+1.65%)
After-Hours: 20:00
Cocrystal Pharma Total Long Term Debt (Quarterly) : 0.989M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.989M |
| March 31, 2026 | 1.081M |
| December 31, 2025 | 1.171M |
| September 30, 2025 | 1.257M |
| June 30, 2025 | 1.341M |
| March 31, 2025 | 1.424M |
| December 31, 2024 | 1.505M |
| September 30, 2024 | 1.582M |
| June 30, 2024 | 1.529M |
| March 31, 2024 | 1.582M |
| December 31, 2023 | 1.613M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.01M |
| March 31, 2023 | 0.027M |
| December 31, 2022 | 0.064M |
| September 30, 2022 | 0.133M |
| June 30, 2022 | 0.198M |
| March 31, 2022 | 0.262M |
| December 31, 2021 | 0.325M |
| September 30, 2021 | 0.387M |
| June 30, 2021 | 0.323M |
| March 31, 2021 | 0.372M |
| December 31, 2020 | 0.418M |
| September 30, 2020 | 0.465M |
| June 30, 2020 | 0.519M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.535M |
| December 31, 2019 | 0.64M |
| September 30, 2019 | 0.741M |
| June 30, 2019 | 0.839M |
| March 31, 2019 | 0.936M |
| December 31, 2018 | 0.331M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 2.039M |
| December 31, 2017 | 1.007M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 6.30M |
| Fulcrum Therapeutics, Inc. | 2.76M |
| Definium Therapeutics, Inc. | 36.47M |